Lifshitz & Miller Law Firm Announces Investigation of 3D Systems Corporation, Avalanche Biotechnologies, Inc., FXCM Inc., KYTHERA Biopharmaceuticals, Inc., root9B Technologies Inc., and Ryland Gro

NEW YORK, June 19, 2015 /PRNewswire/ --

3D Systems Corporation

Lifshitz & Miller  announces investigation into possible breaches of fiduciary duties by the board of 3D Systems Corporation (DDD).  Specifically, we are investigating DDD's representations in connection with DDD's (i) ability to increase the capacity of its metal printing business; (ii) demand for its consumer products; (iii) the value of multiple companies it was acquiring; and (iv) expected earnings.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: [email protected].

Avalanche Biotechnologies, Inc.

Lifshitz & Miller  announces investigation into possible breaches of fiduciary duties by the board of Avalanche Biotechnologies, Inc. (AAVL).  Specifically, on June 15, 2015, AAVL announced that AAVL's treatment for wet age-related macular degeneration met its primary endpoint, but raised concerns by saying the study wasn't designed to show statistically significant differences between the active and control subjects in the secondary endpoints.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: [email protected].

FXCM Inc.

Lifshitz & Miller  announces investigation into possible breaches of fiduciary duties by the board of FXCM Inc. (FXCM).  Specifically, we are investigating FXCM's representations in connection with FXCM's agency model of FX trading insulating it from financial risk from its heavily leveraged clients, whether FXCM adequately disclosed the true potential risk posed by market volatility, and whether FXCM maintained sufficient regulatory capital reserves for unforeseen scenarios.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: [email protected].

KYTHERA Biopharmaceuticals, Inc.

Lifshitz & Miller  announces investigation into possible breaches of fiduciary duties by the board in connection with the proposed sale of  KYTHERA Biopharmaceuticals, Inc. (KYTH) to Allergan plc for $75 per share, or approximately $2.1 billion.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: [email protected].

root9B Technologies Inc.

Lifshitz & Miller  announces investigation into possible breaches of fiduciary duties by the board of root9B Technologies Inc. (RTNB).  Specifically, on June 15, 2015, an author on SeekingAlpha.com reported that it believes RTNB is a worthless reverse merger shell led by the "The A-Team" of penny stock wipeouts, questionable board members who have presided over untold shareholder wealth destruction, and a management team with ties to numerous fraud allegations.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: [email protected].

Ryland Group Inc.

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties in connection with the proposed sale of Ryland Group Inc. ("RYL") to Standard Pacific Corp.  Ryland shareholders will own approximately 41% of the combined company.  

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: [email protected].

ATTORNEY ADVERTISING. © 2015 Lifshitz & Miller.  The law firm responsible for this advertisement is Lifshitz & Miller, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516) 493-9780.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:Joshua M. Lifshitz, Esq.Lifshitz & MillerPhone:  516-493-9780 Facsimile: 516-280-7376Email: [email protected]

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lifshitz--miller-law-firm-announces-investigation-of-3d-systems-corporation-avalanche-biotechnologies-inc-fxcm-inc-kythera-biopharmaceuticals-inc-root9b-technologies-inc-and-ryland-group-inc-300102080.html

SOURCE Lifshitz & Miller Law Firm